Knome aids in Parkinson's gene discovery

Knome, a Cambridge, MA-based genome interpretation firm, used its proprietary DNA analysis software to help Canadian researchers uncover a gene variant that appears to be linked to late-onset Parkinson's disease. Researchers from the University of British Columbia who led the study, published last week in The American Journal of Human Genetics, found that a mutation in the gene for vacuolar protein-sorting associated protein 35 is a biomarker for the neurodegenerative disease. Story

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.